journal根拠レベル B独立情報源
根拠ページOne and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors (Niederwieser D, et al., Haematologica 107(5):1045-1053)
Haematologica
閲覧日 2026年9月20日更新 2026年9月20日
原典
https://pmc.ncbi.nlm.nih.gov/articles/PMC9052915/
pmc.ncbi.nlm.nih.gov
検証
| 検証 | 対象から独立した出典 |
| 根拠レベル | B · 査読・専門団体 |
| 独立情報源 | 対象から独立した情報源 |
| 出典 | journal |
| リンク状態 | 最終確認時にアクセス可能 |
公式な主張は提供者の声明であり、特に記載がない限りworldwikiが検証したものではありません。 出典ポリシー
引用元ページ (14)
AnswerIs stem cell therapy FDA approved?AnswerWhat conditions can stem cell therapy treat?AnswerWhat are the risks of stem cell therapy?AnswerHow do I know if a stem cell clinic is legitimate?AnswerIs stem cell therapy legal in South Korea?AnswerWhat is the difference between adult stem cells and embryonic stem cells?AnswerWhere are adult stem cells found in the body?AnswerWhat diseases are treated with adult stem cells?AnswerAre mesenchymal stem cell treatments FDA approved?AnswerSVF와 줄기세포의 차이는 무엇인가?Answer자가 줄기세포 의미와 종류는 무엇인가요?Answer줄기세포 의료, 현재 실제 치료에 쓰이는 분야는 어디까지인가요?ArticleStem Cell Therapy: Established Uses, Approved Products, Risks and How to Check a TreatmentArticleAdult Stem Cell (Somatic Stem Cell): Definition, Types, Established Uses and Evidence